TRIM21 and breast carcinoma: In breast cancer, overexpression of TRIM21/Ro52 promotes ubiquitination and degradation of Snail, resulting in the downregulation of E-cadherin transcription throughout the epithelial–mesenchymal transition process, thereby inhibiting migration and invasion capabilities in breast cancer cells [44].